{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Perinatal+Infections&page=2", "query": { "condition": "Perinatal Infections", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Perinatal+Infections&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-22T00:24:15.586Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02898688", "title": "P3+ Intervention Phase", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vaccination" ], "interventions": [ { "name": "Control Site", "type": "BEHAVIORAL" }, { "name": "Intervention Site", "type": "BEHAVIORAL" }, { "name": "Patient-level Control Group", "type": "BEHAVIORAL" }, { "name": "Patient-level Intervention Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 2200, "start_date": "2017-06-12", "completion_date": "2020-07-06", "has_results": false, "last_update_posted_date": "2020-08-05", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 23, "location_summary": "Aurora, Colorado • Boulder, Colorado • Denver, Colorado + 12 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02898688" }, { "nct_id": "NCT02119702", "title": "Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV/AIDS" ], "interventions": [], "intervention_types": [], "sponsor": "Harvard School of Public Health (HSPH)", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 818, "start_date": "2014-04", "completion_date": "2025-05-31", "has_results": false, "last_update_posted_date": "2025-06-27", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 13, "location_summary": "La Jolla, California • Aurora, Colorado • Fort Lauderdale, Florida + 9 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02119702" }, { "nct_id": "NCT06172660", "title": "Real-World Effectiveness of Perinatal RSV Immunoprophylaxis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "RSV Infection" ], "interventions": [ { "name": "Nirsevimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "12 Months", "sex": "ALL", "summary": "Up to 12 Months" }, "enrollment_count": 3750, "start_date": "2024-10-28", "completion_date": "2028-12-30", "has_results": false, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06172660" }, { "nct_id": "NCT03069417", "title": "Support for Perinatal Adherence and Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Human Immunodeficiency Virus", "Depression" ], "interventions": [ { "name": "Integrating Nuanced Support for Perinatal adherence and Depression", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 23, "start_date": "2016-11-09", "completion_date": "2017-10-31", "has_results": true, "last_update_posted_date": "2021-12-14", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03069417" }, { "nct_id": "NCT03997266", "title": "NICU Antibiotics and Outcomes Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Microbial Colonization", "Extreme Prematurity", "Early-Onset Neonatal Sepsis", "Late-Onset Neonatal Sepsis", "Necrotizing Enterocolitis of Newborn", "Death; Neonatal" ], "interventions": [ { "name": "Ampicillin", "type": "DRUG" }, { "name": "Gentamycin", "type": "DRUG" }, { "name": "Normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Michael Morowitz", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "4 Hours", "sex": "ALL", "summary": "Up to 4 Hours" }, "enrollment_count": 359, "start_date": "2020-08-05", "completion_date": "2026-01-15", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 14, "location_summary": "Mobile, Alabama • San Diego, California • New Haven, Connecticut + 10 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Tampa", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03997266" }, { "nct_id": "NCT06168019", "title": "Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Influenza", "COVID-19", "SARS-COV-2 Infection", "Other Respiratory Viruses", "Perinatal Morbidity", "Infant Morbidity" ], "interventions": [ { "name": "Exposures", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Boston University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 10000, "start_date": "2023-12-26", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2025-11-28", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06168019" }, { "nct_id": "NCT04704024", "title": "Reducing Vertical Transmission of Hepatitis B in Africa", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis B Infection" ], "interventions": [ { "name": "Tenofovir Disoproxil Fumarate", "type": "DRUG" }, { "name": "Lamivudine Oral Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "16 Years to 50 Years · Female only" }, "enrollment_count": 450, "start_date": "2021-09-03", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04704024" }, { "nct_id": "NCT05013944", "title": "AnovaOS Network Powered Patient Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Infectious Disease", "Neoplasms", "Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)", "Endocrine, Nutritional and Metabolic Diseases (E00-E89)", "Mental and Behavioural Disorders", "Diseases of the Nervous System", "Diseases of the Eye and Adnexa", "Diseases of the Ear and Mastoid Process", "Diseases of the Circulatory System", "Diseases of the Respiratory System", "Diseases of the Digestive System", "Diseases of the Skin and Subcutaneous Tissue", "Diseases of the Musculoskeletal System and Connective Tissue", "Diseases of the Genitourinary System", "Pregnancy, Childbirth and the Puerperium", "Certain Conditions Originating in the Perinatal Period", "Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)", "Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified", "Injury, Poisoning and Certain Other Consequences of External Causes", "External Causes of Morbidity and Mortality", "Factors Influencing Health Status and Contact With Health Services" ], "interventions": [], "intervention_types": [], "sponsor": "Anova Enterprises, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100000, "start_date": "2021-09-01", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2024-01-30", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 1, "location_summary": "Arlington Heights, Illinois", "locations": [ { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05013944" }, { "nct_id": "NCT00099359", "title": "Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Disease Transmission, Vertical", "Vertical Human Immunodeficiency Virus Transmission", "HIV Infections" ], "interventions": [ { "name": "Zidovudine", "type": "DRUG" }, { "name": "Nevirapine (NVP)", "type": "DRUG" }, { "name": "Epivir (3TC)", "type": "DRUG" }, { "name": "Nelfinavir (NFV)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "2 Days", "sex": "ALL", "summary": "Up to 2 Days" }, "enrollment_count": 1735, "start_date": "2004-02", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2012-12-04", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 5, "location_summary": "Long Beach, California • Gainesville, Florida • Jacksonville, Florida + 2 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Newark", "state": "New Jersey" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00099359" }, { "nct_id": "NCT00992836", "title": "Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections", "H1N1 Influenza Virus" ], "interventions": [ { "name": "Influenza A (H1N1) 2009 monovalent vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "4 Years to 25 Years" }, "enrollment_count": 155, "start_date": "2009-10", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2021-11-05", "last_synced_at": "2026-07-22T00:24:15.586Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Alhambra, California • La Jolla, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Alhambra", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00992836" } ] }